Bupa Global and UK profits dip due to Covid closures

Iñaki Ereño, group chief executive officer, Bupa

Reduced revenue from healthcare services and insurance premium rebates paid to customers as a result of the Covid-19 pandemic have dented UK profits at global healthcare giant Bupa. Revenue for the year ended 31 December 2020 was down 6% at constant exchange rates to £3.1bn across the Bupa Global and UK business, which includes dentistry,…

You must be a HM Subscriber to view this content.

Subscribe Now »